Regen Biopharma's market cap is currently ―. The company's EPS TTM is $-0.239; its P/E ratio is -2.71; Regen Biopharma is scheduled to report earnings on May 14, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 31.64K	$ 31.64K	$ 31.64K	$ 59.06K	$ 59.37K
Gross Profit	$ 31.64K	$ 31.64K	$ 31.64K	-	-
EBIT	$ -332.00K	$ -85.16K	$ 196.97K	$ 1.65M	$ -42.84K
EBITDA	$ -327.63K	$ 0.00	$ 196.97K	$ 1.65M	$ -42.84K
Net Income Common Stockholders	$ -349.76K	$ -99.22K	$ 184.89K	$ 1.45M	$ -67.58K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 124.50K	$ 692.00	$ 87.70K	$ 40.74K	$ 51.20K
Total Assets	$ 159.53K	$ 285.20K	$ 406.63K	$ 414.11K	$ 559.00K
Total Debt	$ 704.07K	$ 601.59K	$ 601.59K	$ 511.59K	$ 1.27M
Net Debt	$ 579.57K	$ 600.90K	$ 513.89K	$ 470.85K	$ 1.22M
Total Liabilities	$ 5.40M	$ 5.31M	$ 5.34M	$ 5.30M	$ 8.60M
Stockholders Equity	$ -5.24M	$ -5.03M	$ -4.93M	$ -4.88M	$ -8.04M
Cash Flow	-
Free Cash Flow	$ -162.34K	-	$ 46.96K	$ -10.46K	$ -85.29K
Operating Cash Flow	$ -162.34K	-	$ 46.96K	$ -10.46K	$ -85.29K
Investing Cash Flow	-	-	-	$ 0.00	-
Financing Cash Flow	$ 165.80K	-	-	$ 0.00	$ 499.00

Currency in USD

Regen Biopharma Earnings and Revenue History

Income Statement >

Regen Biopharma Debt to Assets

Balance Sheet >

Regen Biopharma Cash Flow

Cash Flow >

Regen Biopharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing